We Are Tomodachi Spring / Summer 2016

9/40

9Global scale of the regenerative medicine marketThe future scale of the global market for regenerative medicine is forecast to grow to JPY 1 trillion (USD 9 billion) by 2020 and JPY 38 trillion (USD 345 billion) by 2050.Shortening of development period under expedited approval systemTwo regenerative medicalproducts approvedBy comparison with the previous approval process, this system provides for a major shortening of the time required for approval of pharmaceuticals, subject to further confirmation after marketing, followed by a review of the approval. A medical field drawing global attentionExamples of regenerative medicine using iPS cells, embryonic stem cells, and somatic stem cells, now drawing attention for its potential in curing previously untreatable conditions.Yuzo Toda, Representative Director, ChairmanForum for Innovative Regenerative Medicine (FIRM) JCR Pharmaceuticals: TemCell (allogenic mesenchymal stromal cells)Terumo: HeartSheet(autologous skeletal muscle cells)FIRM, with 185 corporate members as of January 2016, is working to close gaps in awareness and regulations regarding regenerative medicine among industry, academia, government, and citizens, as well as to show specific ways forward.

※このページを正しく表示するにはFlashPlayer10.2以上が必要です